{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:19:03Z","timestamp":1790144343230,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.hoc.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T20:19:45Z","timestamp":1543263585000},"page":"25-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Cutaneous Melanoma\u2014A Review in Detection, Staging, and Management"],"prefix":"10.1016","volume":"33","author":[{"given":"Rebecca I.","family":"Hartman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2018.09.005_bib1","unstructured":"Institute NC. SEER cancer stat facts: melanoma of the skin."},{"key":"10.1016\/j.hoc.2018.09.005_bib2","unstructured":"Australia C. Melanoma of the skin statistics."},{"key":"10.1016\/j.hoc.2018.09.005_bib3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1634\/theoncologist.11-6-590","article-title":"Epidemiology, access, and outcomes: SEER series cancer in 15- to 29-year-olds by primary site","volume":"11","author":"Bleyer","year":"2006","journal-title":"Oncologist"},{"issue":"21","key":"10.1016\/j.hoc.2018.09.005_bib4","first-page":"591","article-title":"Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030","volume":"64","author":"Guy","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.hoc.2018.09.005_bib5","doi-asserted-by":"crossref","first-page":"e4757","DOI":"10.1136\/bmj.e4757","article-title":"Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis","volume":"345","author":"Boniol","year":"2012","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.hoc.2018.09.005_bib6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1470-2045(09)70213-X","article-title":"A\u00a0review of human carcinogens--part D: radiation","volume":"10","author":"El Ghissassi","year":"2009","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2018.09.005_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jmg.2010.086538","article-title":"Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK","volume":"48","author":"Cust","year":"2011","journal-title":"J\u00a0Med Genet"},{"issue":"8","key":"10.1016\/j.hoc.2018.09.005_bib8","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The national cancer data base report on cutaneous and noncutaneous melanoma","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2018.09.005_bib9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ijc.24747","article-title":"Clinical whole-body skin examination reduces the incidence of thick melanomas","volume":"126","author":"Aitken","year":"2010","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2018.09.005_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jama.2016.8465","article-title":"Screening for skin cancer","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.hoc.2018.09.005_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaad.2010.11.016","article-title":"Systematic skin cancer screening in Northern Germany","volume":"66","author":"Breitbart","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.hoc.2018.09.005_bib12","first-page":"740","article-title":"Dermoscopy for melanoma detection in family practice","volume":"58","author":"Herschorn","year":"2012","journal-title":"Can Fam Physician"},{"issue":"3","key":"10.1016\/j.hoc.2018.09.005_bib13","first-page":"669","article-title":"Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting","volume":"159","author":"Vestergaard","year":"2008","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.hoc.2018.09.005_bib14","first-page":"268","article-title":"Digital monitoring by whole body photography and sequential digital dermoscopy detects thinner melanomas","volume":"2","author":"Rademaker","year":"2010","journal-title":"J\u00a0Prim Health Care"},{"issue":"8","key":"10.1016\/j.hoc.2018.09.005_bib15","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/jdv.14791","article-title":"Dermoscopy vs. reflectance confocal microscopy for the diagnosis of lentigo maligna","volume":"32","author":"Cinotti","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.hoc.2018.09.005_bib16","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American joint committee on cancer eighth edition Cancer Staging Man","volume":"67","author":"Gershenwald","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.hoc.2018.09.005_bib17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaad.2012.08.005","article-title":"The rate of melanoma transection with various biopsy techniques and the influence of tumor transection on patient survival","volume":"68","author":"Mir","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2018.09.005_bib18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1309\/AJCPWSDDHLLW40WI","article-title":"Fine-needle aspiration cytology for the diagnosis of metastatic melanoma: Systematic review and meta-analysis","volume":"140","author":"Hall","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2018.09.005_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.soc.2014.12.002","article-title":"Pathology of melanoma","volume":"24","author":"Elder","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"issue":"3","key":"10.1016\/j.hoc.2018.09.005_bib20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/PAS.0b013e3181cf7fa0","article-title":"Melanocytic tumors of uncertain malignant potential: Results of a tutorial held at the XXIX symposium of the international society of dermatopathology in Graz, October 2008","volume":"34","author":"Cerroni","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2018.09.005_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaad.2013.07.027","article-title":"The MPATH-Dx reporting schema for melanocytic proliferations and melanoma","volume":"70","author":"Piepkorn","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.hoc.2018.09.005_bib22","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","article-title":"Melanoma staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond","volume":"25","author":"Gershenwald","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.hoc.2018.09.005_bib23","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Akbani","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.hoc.2018.09.005_bib24","first-page":"809","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"361","author":"Flaherty","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2018.09.005_bib25","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/jid.2014.452","article-title":"More people die from thin melanomas (\u22641\u00a0mm) than from thick melanomas (>4\u00a0mm) in Queensland, Australia","volume":"135","author":"Whiteman","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.hoc.2018.09.005_bib26","article-title":"Identification of patients at risk for metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria","author":"Gastman","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.hoc.2018.09.005_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaad.2017.08.039","article-title":"Determination of the impact of melanoma surgical timing on survival using the National Cancer Database","volume":"78","author":"Conic","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"SUPPL. 4","key":"10.1016\/j.hoc.2018.09.005_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/annonc\/mdp257","article-title":"Surgery and radiotherapy in the treatment of cutaneous melanoma","volume":"20","author":"Testori","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2018.09.005_bib29","doi-asserted-by":"crossref","unstructured":"Fleming MD. NCCN evidence blocks TM. 2017:2016. doi:10.1007\/978-1-84996-314-5.","DOI":"10.1007\/978-1-84996-314-5"},{"issue":"13","key":"10.1016\/j.hoc.2018.09.005_bib30","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2018.09.005_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.6004\/jnccn.2009.0023","article-title":"Role of sentinel lymph node biopsy in patients with thin melanoma","volume":"7","author":"Andtbacka","year":"2009","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"issue":"23","key":"10.1016\/j.hoc.2018.09.005_bib32","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2018.09.005_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2011.06.029","article-title":"Grenz ray treatment of lentigo maligna and early lentigo maligna melanoma","volume":"67","author":"Hedblad","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2018.09.005_bib34","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/bjd.15112","article-title":"Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study","volume":"176","author":"Marsden","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.hoc.2018.09.005_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/CMR.0000000000000139","article-title":"The emerging role of radiotherapy for desmoplastic melanoma and implications for future research","volume":"25","author":"Oliver","year":"2015","journal-title":"Melanoma Res"},{"issue":"8","key":"10.1016\/j.hoc.2018.09.005_bib36","first-page":"711","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010"},{"issue":"17","key":"10.1016\/j.hoc.2018.09.005_bib37","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2014.56.2736","article-title":"Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma","volume":"33","author":"Schadendorf","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2018.09.005_bib38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2018.09.005_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial","volume":"16","author":"Weber","year":"2015","journal-title":"Lancet Oncol"},{"issue":"21","key":"10.1016\/j.hoc.2018.09.005_bib40","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2018.09.005_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.hoc.2018.09.005_bib42","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.hoc.2018.09.005_bib43","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2018.09.005_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.hoc.2018.09.005_bib45","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","article-title":"Combined vemurafenib and cobimetinib in BRAF -mutated melanoma","volume":"371","author":"Larkin","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.hoc.2018.09.005_bib46","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","article-title":"Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma","volume":"371","author":"Long","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2018.09.005_bib47","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","author":"Weber","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2018.09.005_bib48","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","author":"Eggermont","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2018.09.005_bib49","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF -mutated melanoma","author":"Long","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2018.09.005_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/JCO.2010.28.7078","article-title":"Reduced melanoma after regular sunscreen use: Randomized trial follow-up","volume":"29","author":"Green","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2018.09.005_bib51","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40257-016-0221-5","article-title":"Primary and secondary chemoprevention of malignant melanoma","volume":"17","author":"Mounessa","year":"2016","journal-title":"Am J Clin Dermatol"},{"issue":"15","key":"10.1016\/j.hoc.2018.09.005_bib52","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.ejca.2014.06.024","article-title":"Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis","volume":"50","author":"Caini","year":"2014","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2018.09.005_bib53","first-page":"6873","article-title":"Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma","volume":"8","author":"Timerman","year":"2017"},{"issue":"1","key":"10.1016\/j.hoc.2018.09.005_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3538-4","article-title":"Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial","volume":"17","author":"De Smedt","year":"2017","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2018.09.005_bib55","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1755-148X.2011.00873.x","article-title":"Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma","volume":"24","author":"Devitt","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"issue":"21","key":"10.1016\/j.hoc.2018.09.005_bib56","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","article-title":"KIT gene mutations and copy number in melanoma subtypes","volume":"14","author":"Beadling","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818307937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818307937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:10:56Z","timestamp":1760184656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858818307937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0889858818307937"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2018.09.005","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous Melanoma\u2014A Review in Detection, Staging, and Management","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}